Cassava Sciences

About:

Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.

Website: https://www.cassavasciences.com/

Top Investors: National Institutes of Health

Description:

Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.

Total Funding Amount:

$257M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Austin, Texas, United States

Founded Date:

1998-01-01

Founders:

Remi Barbier

Number of Employees:

11-50

Last Funding Date:

2022-11-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai